Robert W. Postma
Director, ZIOPHARM Oncology.
Companies
- ZIOPHARM OncologyBoard member Mar 22, 2021 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- ZIOPHARM Oncology TCRT121,025 shares2$263.8K at $2.18Jul 27, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 23, 2026Granted 8,463 shares at $1.92 of ZIOPHARM Oncology2
- Apr 29, 2026Granted 6,274 shares at $2.59 of ZIOPHARM Oncology3
- Jan 12, 2026Granted 5,622 shares at $2.89 of ZIOPHARM Oncology4
- Nov 21, 2025Granted 5,142 shares at $3.16 of ZIOPHARM Oncology5
- Jul 3, 2025Granted 4,050 shares of ZIOPHARM Oncology6
- Apr 13, 2025Granted 20,804 shares at $2.92 of ZIOPHARM Oncology7
- Apr 13, 2025Granted 20,804 shares at $2.92 of ZIOPHARM Oncology8
- Nov 29, 2022Bought 750,000 shares at $0.65 of ZIOPHARM Oncology9
- Jun 22, 2022Granted 40,000 shares of ZIOPHARM Oncology10
- Jun 22, 2022Granted 40,000 shares of ZIOPHARM Oncology11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARZIOPHARM Oncology, Board member
- 2
- 3SEC EDGARForm 4 filed May 1, 2026
- 4SEC EDGARForm 4 filed Jan 15, 2026
- 5SEC EDGARForm 4 filed Nov 26, 2025
- 6SEC EDGARForm 4 filed Jul 7, 2025
- 7SEC EDGARForm 4 filed Jun 26, 2025
- 8SEC EDGARForm 4 filed Apr 15, 2025
- 9SEC EDGARForm 4 filed Dec 1, 2022
- 10SEC EDGARForm 4 filed Jun 24, 2022
- 11SEC EDGARForm 4 filed Jun 24, 2022